PLIANT THERAPEUTICS, INC. Annual Operating Income (Loss) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Pliant Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2019 to 2023.
  • Pliant Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$62M, a 30% decline year-over-year.
  • Pliant Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$222M, a 27.3% decline year-over-year.
  • Pliant Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$184M, a 44.8% decline from 2022.
  • Pliant Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$127M, a 30.4% decline from 2021.
  • Pliant Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$97.5M, a 134% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$184M -$56.9M -44.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 -$127M -$29.7M -30.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 -$97.5M -$55.9M -134% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 -$41.6M -$40.4M -3283% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-01
2019 -$1.23M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.